Intl. Biotechnology Trust PLC Portfolio Update (2383U)
21 October 2017 - 12:51AM
UK Regulatory
TIDMIBT
RNS Number : 2383U
Intl. Biotechnology Trust PLC
20 October 2017
INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)
Portfolio Update as at 30 September 2017
Net Assets GBP241m
Net Assets per share 642p
Share price 605p
Total value of unquoted GBP17m
investments
Total number of portfolio
companies 93
Dividend 4% of NAV
per annum
Top Ten Quoted Investments
Company Name % NAV
Celgene 8.1
Biogen 6.9
Regeneron 5.7
Vertex 4.2
Alexion 4.0
Shire 3.6
Incyte 3.2
Gilead 3.1
Acadia 2.8
Adamas 2.6
-----------
Total 44.2
Geographical Allocation % NAV
US & Canada 86
Europe & UK 14
-----------
Total 100
Quoted/Unquoted Allocation % NAV
Quoted 91
Unquoted 9
-----------
Total 100
NAV % Market Cap % NAV
Large Cap >USD10BN 45
Mid Cap =USD1-10BN 31
Small Cap <USD1BN 24
-----------
Total 100
NAV % by Therapeutic Areas % NAV
Oncology 35
Rare diseases 15
CNS 13
Ophthalmology 8
Inflammation 8
Infectious Diseases 5
Metabolic 5
Medtech 2
Other 9
-----------
Total 100
BNP Paribas Secretarial Services Limited
Company Secretary
20 OCTOBER 2017
This information is provided by RNS
The company news service from the London Stock Exchange
END
PFUBXBDGISDBGRG
(END) Dow Jones Newswires
October 20, 2017 09:51 ET (13:51 GMT)
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From Apr 2024 to May 2024
International Biotechnol... (LSE:IBT)
Historical Stock Chart
From May 2023 to May 2024